Home › Metastatic Cancer › Missouri › Springfield
Metastatic Cancer clinical trials in Springfield, MO
6 studies for Metastatic Cancer are looking for participants at sites in and around Springfield (within about 30 miles). Open a study to see who can join and how to contact the study team.
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Mercy Hospital Springfield, Springfield
- CoxHealth South Hospital, Springfield
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RecruitingPhase 3
- Oncology Hematology Associates, Springfield
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RecruitingPhase 3
- Oncology Hematology Associates, Springfield
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RecruitingPhase 3
- Cox Medical Center North, Springfield
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecruitingPhase 3
- Oncology Hematology Associates, Springfield
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
RecruitingObservational study
- Mercy Hospital Springfield, Springfield
- CoxHealth South Hospital, Springfield
Metastatic Cancer trials in other cities
- Houston, TX104 studies
- New York City, NY93 studies
- Nashville, TN69 studies
- Boston, MA63 studies
- Los Angeles, CA57 studies
- St. Louis, MO53 studies
- Arlington, VA53 studies
- Philadelphia, PA46 studies
- Chicago, IL45 studies
- San Antonio, TX44 studies
- Washington, DC43 studies
- Dallas, TX42 studies
Other studies in Springfield
- Colorectal Cancer11 studies
- Cancer (all types)11 studies
- Breast Cancer10 studies
- Non-Small Cell Lung Cancer10 studies
- Obesity7 studies
- Overweight7 studies
- Melanoma6 studies
- Lung Cancer6 studies
- Endometrial Cancer5 studies
- Colon Cancer5 studies
- Ovarian Cancer5 studies
- Bladder Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.